Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.

Núñez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S, Brosnan-Cashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, Lyssiotis CA, Jones L, Herting CJ, Ross JL, Hambardzumyan D, Hervey-Jumper S, Figueroa ME, Lowenstein PR, Castro MG.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaaq1427. doi: 10.1126/scitranslmed.aaq1427.

2.

High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.

Kadiyala P, Li D, Nuñez FM, Altshuler D, Doherty R, Kuai R, Yu M, Kamran N, Edwards M, Moon JJ, Lowenstein PR, Castro MG, Schwendeman A.

ACS Nano. 2019 Feb 26;13(2):1365-1384. doi: 10.1021/acsnano.8b06842. Epub 2019 Feb 11.

3.

Current state and future prospects of immunotherapy for glioma.

Kamran N, Alghamri MS, Nunez FJ, Shah D, Asad AS, Candolfi M, Altshuler D, Lowenstein PR, Castro MG.

Immunotherapy. 2018 Feb 1;10(4):317-339. doi: 10.2217/imt-2017-0122. Review.

4.

Melanoma induced immunosuppression is mediated by hematopoietic dysregulation.

Kamran N, Li Y, Sierra M, Alghamri MS, Kadiyala P, Appelman HD, Edwards M, Lowenstein PR, Castro MG.

Oncoimmunology. 2017 Dec 14;7(3):e1408750. doi: 10.1080/2162402X.2017.1408750. eCollection 2018. Erratum in: Oncoimmunology. 2018 Feb 1;7(4):e1431073.

5.

Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.

Kamran N, Kadiyala P, Saxena M, Candolfi M, Li Y, Moreno-Ayala MA, Raja N, Shah D, Lowenstein PR, Castro MG.

Mol Ther. 2017 Jan 4;25(1):232-248. doi: 10.1016/j.ymthe.2016.10.003. Epub 2017 Jan 4.

6.

Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.

Kamran N, Chandran M, Lowenstein PR, Castro MG.

Clin Immunol. 2018 Apr;189:34-42. doi: 10.1016/j.clim.2016.10.008. Epub 2016 Oct 21. Review.

7.

Recent advances and future of immunotherapy for glioblastoma.

Kamran N, Calinescu A, Candolfi M, Chandran M, Mineharu Y, Asad AS, Koschmann C, Nunez FJ, Lowenstein PR, Castro MG.

Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27. Review.

8.

ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.

Koschmann C, Calinescu AA, Nunez FJ, Mackay A, Fazal-Salom J, Thomas D, Mendez F, Kamran N, Dzaman M, Mulpuri L, Krasinkiewicz J, Doherty R, Lemons R, Brosnan-Cashman JA, Li Y, Roh S, Zhao L, Appelman H, Ferguson D, Gorbunova V, Meeker A, Jones C, Lowenstein PR, Castro MG.

Sci Transl Med. 2016 Mar 2;8(328):328ra28. doi: 10.1126/scitranslmed.aac8228.

9.

Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms.

Kamran N, Candolfi M, Baker GJ, Ayala MM, Dzaman M, Lowenstein PR, Castro MG.

Methods Mol Biol. 2016;1382:467-82. doi: 10.1007/978-1-4939-3271-9_31.

10.

Overview of current immunotherapeutic strategies for glioma.

Calinescu AA, Kamran N, Baker G, Mineharu Y, Lowenstein PR, Castro MG.

Immunotherapy. 2015;7(10):1073-104. doi: 10.2217/imt.15.75. Review.

11.

Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.

Karim F, Moiz B, Kamran N.

Transfus Apher Sci. 2015 Feb;52(1):99-102. doi: 10.1016/j.transci.2014.12.002. Epub 2014 Dec 11.

PMID:
25532481
12.

Blockade of mTOR signaling via rapamycin combined with immunotherapy augments antiglioma cytotoxic and memory T-cell functions.

Mineharu Y, Kamran N, Lowenstein PR, Castro MG.

Mol Cancer Ther. 2014 Dec;13(12):3024-36. doi: 10.1158/1535-7163.MCT-14-0400. Epub 2014 Sep 25.

13.

Adenoviral vector-mediated gene therapy for gliomas: coming of age.

Castro MG, Candolfi M, Wilson TJ, Calinescu A, Paran C, Kamran N, Koschmann C, Moreno-Ayala MA, Assi H, Lowenstein PR.

Expert Opin Biol Ther. 2014 Sep;14(9):1241-57. doi: 10.1517/14712598.2014.915307. Epub 2014 Apr 29. Review.

14.

Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.

Candolfi M, Yagiz K, Wibowo M, Ahlzadeh GE, Puntel M, Ghiasi H, Kamran N, Paran C, Lowenstein PR, Castro MG.

Clin Cancer Res. 2014 Mar 15;20(6):1555-1565. doi: 10.1158/1078-0432.CCR-13-2140. Epub 2014 Feb 5.

15.

Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells.

Kamran N, Takai Y, Miyoshi J, Biswas SK, Wong JS, Gasser S.

PLoS One. 2013;8(1):e54406. doi: 10.1371/journal.pone.0054406. Epub 2013 Jan 17.

16.

ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.

Croxford JL, Tang ML, Pan MF, Huang CW, Kamran N, Phua CM, Chng WJ, Ng SB, Raulet DH, Gasser S.

Blood. 2013 Mar 28;121(13):2512-21. doi: 10.1182/blood-2012-08-449025. Epub 2013 Jan 24.

17.

Ras activation induces expression of Raet1 family NK receptor ligands.

Liu XV, Ho SS, Tan JJ, Kamran N, Gasser S.

J Immunol. 2012 Aug 15;189(4):1826-34. doi: 10.4049/jimmunol.1200965. Epub 2012 Jul 13.

18.

Pleural fluid plasmacytosis in a patient with plasma cell leukemia.

Sajid R, Moiz B, Kamran N, Adil SN.

Turk J Haematol. 2010 Jun 5;27(2):135-6. doi: 10.5152/tjh.2010.19. No abstract available.

19.

Therapeutic outcomes of older patients with acute myeloid leukemia.

Sajid R, Moiz B, Ali N, Kamran N, Adil AN, Shaikh U, Khurshid M.

Saudi Med J. 2010 May;31(5):533-8.

PMID:
20464043
20.

Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.

Batra G, Raut R, Dahiya S, Kamran N, Swaminathan S, Khanna N.

J Virol Methods. 2010 Jul;167(1):10-6. doi: 10.1016/j.jviromet.2010.03.002. Epub 2010 Mar 6.

PMID:
20211204
21.

Transfusion medicine illustrated: blocked D phenomenon.

Moiz B, Salman M, Kamran N, Shamsuddin N.

Transfusion. 2008 Aug;48(8):1545-6. doi: 10.1111/j.1537-2995.2008.01773.x. No abstract available.

PMID:
18713103
22.

Metastatic signet ring gastric adenocarcinoma presenting with microangiopathic hemolytic anemia.

Ali N, Kamran N, Adil S, Pervez S.

Indian J Gastroenterol. 2007 Jul-Aug;26(4):185-6.

PMID:
17986749
23.

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

Clin Cancer Res. 2007 Mar 1;13(5):1421-8.

24.

Subalgebras of loop algebras and symmetries of the Kadomtsev-Petviashvili equation.

David D, Kamran N, Levi D, Winternitz P.

Phys Rev Lett. 1985 Nov 11;55(20):2111-2113. No abstract available.

PMID:
10032051

Supplemental Content

Loading ...
Support Center